In a recent press release, the World Health Organization has called for increased disclosure of all medical product clinical data, whether or not the trial was successful.
The administration’s most recent release clears up what is necessary for developers to successfully approach specialized medical device advisory committee (MDAC) panels.
Maintaining the balance between speedy device approval and assurance of patient safety requires experienced insight and clinical trial management solutions that focus on efficiency and transparency.
Although the trial process shows strong signs of continued improvement, choosing the right clinical research partner remains crucial to success.
A recent study took advantage of Medical Metrics state-of-the-art Quantitative Motion Analysis, or QMA®, software to track the motion of cervical disk replacements with extreme precision.